Sign in

CIK 0001618835 · Non-accelerated filer<br>Smaller reporting company

Evofem Biosciences, Inc.

Sign in to watch
Ticker
EVFM
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
208527075
Phone
(858) 550-1900
Business address
12400 HIGH BLUFF DRIVE, SUITE 600, SAN DIEGO, CA, 92130
Former names
Neothetics, Inc.
  1. 4 Open-market buy Chief Financial Officer bought 40,594 shares at $0.37 ($15,020)
  2. 4 Open-market buy Chief Executive Officer bought 135,000 shares at $0.38 ($50,625)
  3. 4 Shares withheld for taxes Chief Commercial Officer gave up 19,998 shares (to pay taxes)
  4. 4 Open-market buy Director bought 10,000 shares at $1.17 ($11,650)
  5. 4 Open-market buy Director bought 5,000 shares at $1.20 ($5,990)
  6. 4 Open-market buy Director bought 8,140 shares at $1.31 ($10,663)
  7. 4 Open-market buy Chief Commercial Officer bought 18,180 shares at $1.14 ($20,725)
  8. 4 Open-market buy Chief Financial Officer bought 24,500 shares at $1.03 ($25,235)
  9. 4 Open-market buy Chief Executive Officer bought 50,000 shares at $1.03 ($51,500)
  10. 4 Open-market buy General Counsel and Secretary bought 10,000 shares at $1.03 ($10,250)
  11. 4 Shares withheld for taxes General Counsel and Secretary gave up 42,120 shares (to pay taxes)
  12. 4 Shares withheld for taxes Chief Commercial Officer gave up 31,480 shares (to pay taxes)
  13. 4 Shares withheld for taxes Chief Medical Officer gave up 42,061 shares (to pay taxes)
  14. 4 Shares withheld for taxes Chief Financial Officer gave up 42,280 shares (to pay taxes)
  15. 4 Shares withheld for taxes Chief Executive Officer gave up 105,300 shares (to pay taxes)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 2 of 15 · 281 filings